Mortality and hormone-related exposures in women with diabetes

Diabetes Care

Volumn 22, Issue 2, 1999, Pages 248-252

  Klein, Barbara E K ^a,b   Klein, Ronald ^a   Moss, Scot E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; POPULATION RESEARCH; PREGNANCY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; CONTRACEPTIVES, ORAL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEART DISEASES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MENARCHE; MENOPAUSE; MIDDLE AGED; PARITY; PROTEINURIA; SMOKING; WISCONSIN;

EID: 0032950721     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.2.248     Document Type: Article

References (28)

1. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037, 1992
2. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the nurses health study. N Engl J Med 325:756-762, 1991
3. Stampfer MJ, Colditz GA: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20:47-63, 1991
4. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH: Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110, 1987
5. Henderson BE, Paganini-Hill A, Ross RK: Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151:75-78, 1991
6. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C: Postmenopausal estrogen use and mortality: results from a prospective study in a defined, homogeneous community. Am J Epidemiol 128:606-614, 1988
7. Col NF, Eckman MH, Karas RH, Pauker SG, Goldberg RJ, Ross EM, Orr RK, Wong JB: Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 277:1140-1147, 1997
8. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102-1109, 1987
9. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208, 1995 (Erratum in JAMA 274:1676, 1995.)
10. Petitti DB, Perlman JA, Sidney S: Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 70:289-293, 1987
11. Sidney S, Petitti DB, Quesenberry CP Jr: Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 127:501-508, 1997
12. Psaty BM, Heckbert SR, Atkins D, Lemaitre R. Koepsell TD, Wahl PW, Siscovick DS, Wagner EH: The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 154:1333-1339, 1994
13. Rosenberg L, Armstrong B, Jick H: Myocardial infarction and estrogen therapy in postmenopausal women. N Engl J Med 294:1256-1259, 1976
14. Mann RD, Lis Y, Chukwujindu J, Chanter DO: A study of the association between hormone replacement therapy, smoking and the occurrence of myocardial infarction in women. J Clin Epidemiol 47:307-312, 1994
15. Pfeffer RI, Whipple GH, Kurosaki TT, Chapman JM: Coronary risk and estrogen use in postmenopausal women. Am J Epidemiol 107:479-497, 1978
16. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, for the Heart and Estrogen/Progestin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. JAMA 280:605-613, 1998
17. Cauley JA, Gutai JP, Glynn NW. Paternostro-Bayles M, Cottington E, Kuller LH: Serum estrone concentrations and coronary artery disease in postmenopausal women. Arterioscler Thromb 14:14-18, 1994
18. Scheidt-Nave C, Wingard DL, Barrett-Connor E: Earlier age at natural menopause increases risk of coronary heart disease among older postmenopausal women (Abstract). Am J Epidemiol 134:759, 1991
19. Palmer JR, Rosenberg L, Shapiro S: Reproductive factors and risk of myocardial infarction. Am J Epidemiol 136:408-416, 1992
20. Brussaard HE, Gevers-Leuven JA, Kluft C, Krans HM, van Duyvenvoorde W, Buytenhek R, van der Laarse A, Princen HM: Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arterioscler Thromb Vasc Biol 17:324-330, 1997
21. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520-526, 1984
22. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
23. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension detection and follow-up program. Prev Med 5:207-215, 1976
24. Quick-Step: Fast Hemoglobin Test System. Akron, OH. Isolab, 1981, p. 1-8
25. National Center for Health Statistics: Instruction Manual Part 2a: Instructions for Classifying the Underlying Cause of Death, 1989. Hyattsville. MD, National Center for Health Statistics, 1989 (U.S. Department of Health and Human Services publ. 240-9520045)
26. National Center for Health Statistics: Instruction Manual Part 2c: ICD-9 ACME Decision Tables for Classifying Underlying Causes of Death, 1989. Hyattsville. MD. National Center for Health Statistics. 1989 (U.S. Department of Health and Human Services publ. 240-95200048)
27. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc Ser B 34:187-220, 1972
28. Kaplan RC, Heckbert SR, Weiss NS, Wahl PW, Smith NL, Newton KM, Psaty BM: Postmenopausal estrogens and risk of myocardial infarction in diabetic women Diabetes Care 21:1117-1121, 1998